mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.0068 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
0.0088 |
0.9 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.9 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |